Ovarian cancer arising from the proximal fallopian tube in a patient with a BRCA2 mutation

•BRCA1/2 carriers are at high risk for fallopian tube carcinoma, which can arise in the proximal fallopian tube.•Pathologic analysis of RRBSO specimens should include serial sectioning of the entire tube, not just the fimbriated end.•Concurrent hysterectomy at time of RRBSO may be considered to ensu...

Full description

Saved in:
Bibliographic Details
Published in:Gynecologic oncology reports Vol. 37; p. 100795
Main Authors: Badiner, Nora, Nchako, Corbyn M., Ma, Lucy, Frey, Melissa K.
Format: Journal Article
Language:English
Published: Elsevier Inc 01.08.2021
Elsevier
Subjects:
Case Reports and Case Series
ISSN:2352-5789, 2352-5789
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract •BRCA1/2 carriers are at high risk for fallopian tube carcinoma, which can arise in the proximal fallopian tube.•Pathologic analysis of RRBSO specimens should include serial sectioning of the entire tube, not just the fimbriated end.•Concurrent hysterectomy at time of RRBSO may be considered to ensure all tubal epithelium is resected. Patients with BRCA mutations are at high risk of high grade serous ovarian cancer. A paradigm shift has resulted in the current understanding that many cases of ovarian cancer actually arise from the fimbriated fallopian tube. The case presented here involves fallopian tube carcinoma arising from the cornua of the uterus in a BRCA2 carrier. This case suggests that pathologic analysis of risk-reducing bilateral salpingo-oophorectomy (RRBSO) specimens via serial sectioning and extensively examining the fimbriated end (SEE-FIM) may be insufficient to diagnose all occult lesions of interest. This case also provides a new consideration in the ongoing debate over the role of concurrent hysterectomy at time of RRBSO in BRCA carriers.
AbstractList •BRCA1/2 carriers are at high risk for fallopian tube carcinoma, which can arise in the proximal fallopian tube.•Pathologic analysis of RRBSO specimens should include serial sectioning of the entire tube, not just the fimbriated end.•Concurrent hysterectomy at time of RRBSO may be considered to ensure all tubal epithelium is resected. Patients with BRCA mutations are at high risk of high grade serous ovarian cancer. A paradigm shift has resulted in the current understanding that many cases of ovarian cancer actually arise from the fimbriated fallopian tube. The case presented here involves fallopian tube carcinoma arising from the cornua of the uterus in a BRCA2 carrier. This case suggests that pathologic analysis of risk-reducing bilateral salpingo-oophorectomy (RRBSO) specimens via serial sectioning and extensively examining the fimbriated end (SEE-FIM) may be insufficient to diagnose all occult lesions of interest. This case also provides a new consideration in the ongoing debate over the role of concurrent hysterectomy at time of RRBSO in BRCA carriers.
Patients with BRCA mutations are at high risk of high grade serous ovarian cancer. A paradigm shift has resulted in the current understanding that many cases of ovarian cancer actually arise from the fimbriated fallopian tube. The case presented here involves fallopian tube carcinoma arising from the cornua of the uterus in a BRCA2 carrier. This case suggests that pathologic analysis of risk-reducing bilateral salpingo-oophorectomy (RRBSO) specimens via serial sectioning and extensively examining the fimbriated end (SEE-FIM) may be insufficient to diagnose all occult lesions of interest. This case also provides a new consideration in the ongoing debate over the role of concurrent hysterectomy at time of RRBSO in BRCA carriers.
Patients with BRCA mutations are at high risk of high grade serous ovarian cancer. A paradigm shift has resulted in the current understanding that many cases of ovarian cancer actually arise from the fimbriated fallopian tube. The case presented here involves fallopian tube carcinoma arising from the cornua of the uterus in a BRCA2 carrier. This case suggests that pathologic analysis of risk-reducing bilateral salpingo-oophorectomy (RRBSO) specimens via serial sectioning and extensively examining the fimbriated end (SEE-FIM) may be insufficient to diagnose all occult lesions of interest. This case also provides a new consideration in the ongoing debate over the role of concurrent hysterectomy at time of RRBSO in BRCA carriers.Patients with BRCA mutations are at high risk of high grade serous ovarian cancer. A paradigm shift has resulted in the current understanding that many cases of ovarian cancer actually arise from the fimbriated fallopian tube. The case presented here involves fallopian tube carcinoma arising from the cornua of the uterus in a BRCA2 carrier. This case suggests that pathologic analysis of risk-reducing bilateral salpingo-oophorectomy (RRBSO) specimens via serial sectioning and extensively examining the fimbriated end (SEE-FIM) may be insufficient to diagnose all occult lesions of interest. This case also provides a new consideration in the ongoing debate over the role of concurrent hysterectomy at time of RRBSO in BRCA carriers.
• BRCA1/2 carriers are at high risk for fallopian tube carcinoma, which can arise in the proximal fallopian tube. • Pathologic analysis of RRBSO specimens should include serial sectioning of the entire tube, not just the fimbriated end. • Concurrent hysterectomy at time of RRBSO may be considered to ensure all tubal epithelium is resected. Patients with BRCA mutations are at high risk of high grade serous ovarian cancer. A paradigm shift has resulted in the current understanding that many cases of ovarian cancer actually arise from the fimbriated fallopian tube. The case presented here involves fallopian tube carcinoma arising from the cornua of the uterus in a BRCA2 carrier. This case suggests that pathologic analysis of risk-reducing bilateral salpingo-oophorectomy (RRBSO) specimens via serial sectioning and extensively examining the fimbriated end (SEE-FIM) may be insufficient to diagnose all occult lesions of interest. This case also provides a new consideration in the ongoing debate over the role of concurrent hysterectomy at time of RRBSO in BRCA carriers.
ArticleNumber 100795
Author Ma, Lucy
Nchako, Corbyn M.
Frey, Melissa K.
Badiner, Nora
Author_xml – sequence: 1
  givenname: Nora
  orcidid: 0000-0003-0779-028X
  surname: Badiner
  fullname: Badiner, Nora
  email: nmb9007@nyp.org
  organization: NY Presbyterian Weill Cornell Medical Center, Department of Obstetrics and Gynecology, 525 East 68th Street, Box 122, New York, NY 10065, USA
– sequence: 2
  givenname: Corbyn M.
  orcidid: 0000-0003-3633-4742
  surname: Nchako
  fullname: Nchako, Corbyn M.
  email: cmn9010@nyp.org
  organization: NY Presbyterian Weill Cornell Medical Center, Department of Obstetrics and Gynecology, 525 East 68th Street, Box 122, New York, NY 10065, USA
– sequence: 3
  givenname: Lucy
  surname: Ma
  fullname: Ma, Lucy
  email: xim9009@nyp.org
  organization: NY Presbyterian Weill Cornell Medical Center, Department of Pathology and Laboratory Medicine, 525 East 68th Street, Starr Pavilion, 10th Floor, New York, NY 10021, USA
– sequence: 4
  givenname: Melissa K.
  surname: Frey
  fullname: Frey, Melissa K.
  email: mkf2002@med.cornell.edu
  organization: NY Presbyterian Weill Cornell Medical Center, Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, 525 East 68th Street, Suite J-130, New York, NY 10065, USA
BookMark eNqFkU1v1DAQhiNUREvpH-DkI5dd_J0YIaR2BbRSpUoILlwsx57sevHawUkW-u_xNhWiPZSTPeN53hnP-7I6iilCVb0meEkwkW-3y3XKsKSYkpLAtRLPqhPKBF2IulFH_9yPq7Nh2GKMicCsluJFdcw44aTh9Un1_WZvsjcRWRMtZFSCwcc16nLaoXEDqM_pt9-ZgDoTQuoPpePUAvIRGdSb0UMc0S8_bkp48WV1TtFuGks6xVfV88IMcHZ_nlbfPn38urpcXN98vlqdXy-s4GpciKaVvO1ah1kLVDlmKKGMNs7VwFtOiOsap5wwtu3K9MrVjXRCcEsla7Hr2Gl1Neu6ZLa6z2XafKuT8foukfJamzx6G0AzqWQtgEtCCa-ZUhJz6RorOyCAO1W0Psxa_dTuwNnyuWzCA9GHL9Fv9DrtdVPWKTAuAm_uBXL6OcEw6p0fLIRgIqRp0FRwxjlTlJRSOpfanIYhQ_e3DcH64LHe6oPH-uCxnj0uUPMIsn5edxnHh6fR9zMKxYy9h6wHW9yz4HwGO5Zt-afxd49wG3z01oQfcPs_-A8p8dW6
CitedBy_id crossref_primary_10_1007_s11864_025_01346_0
crossref_primary_10_7759_cureus_60992
crossref_primary_10_1002_ijgo_15436
Cites_doi 10.1016/j.ygyno.2005.06.065
10.1001/jamaoncol.2016.1820
10.1001/jamaoncol.2018.0211
10.1002/cncr.29321
10.1016/S1701-2163(15)30659-9
10.1097/AOG.0000000000003702
10.1016/j.critrevonc.2018.09.018
10.1200/JCO.2007.12.2622
10.1001/jama.2017.7112
10.1016/j.ygyno.2009.12.023
ContentType Journal Article
Copyright 2021 The Authors
2021 The Authors. Published by Elsevier Inc.
2021 The Authors. Published by Elsevier Inc. 2021
Copyright_xml – notice: 2021 The Authors
– notice: 2021 The Authors. Published by Elsevier Inc.
– notice: 2021 The Authors. Published by Elsevier Inc. 2021
DBID 6I.
AAFTH
AAYXX
CITATION
7X8
5PM
DOA
DOI 10.1016/j.gore.2021.100795
DatabaseName ScienceDirect Open Access Titles
Elsevier:ScienceDirect:Open Access
CrossRef
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Open Access Full Text
DatabaseTitle CrossRef
MEDLINE - Academic
DatabaseTitleList


MEDLINE - Academic
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Open Access Full Text
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 2352-5789
ExternalDocumentID oai_doaj_org_article_369675e46121473996046d8c6fe1e0f9
PMC8184500
10_1016_j_gore_2021_100795
S2352578921000990
GroupedDBID .1-
.FO
1P~
457
53G
5VS
AAEDT
AAEDW
AAIKJ
AALRI
AAXUO
AAYWO
ABMAC
ACGFS
ACVFH
ADBBV
ADCNI
ADEZE
ADRAZ
ADVLN
AEUPX
AEVXI
AEXQZ
AFJKZ
AFPUW
AFRHN
AFTJW
AGHFR
AIGII
AITUG
AJUYK
AKBMS
AKRWK
AKYEP
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
AOIJS
APXCP
BCNDV
EBS
EJD
FDB
GROUPED_DOAJ
HYE
IPNFZ
KQ8
M41
M48
M~E
OK1
PH~
RIG
ROL
RPM
SSZ
Z5R
0SF
6I.
AACTN
AAFTH
AFCTW
NCXOZ
AAYXX
CITATION
7X8
5PM
ID FETCH-LOGICAL-c549t-58b64bfbd03be29d3a212328dd7e4b411df8d9d5acbf7659d786d554c263b0df3
IEDL.DBID DOA
ISICitedReferencesCount 3
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000701677400011&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 2352-5789
IngestDate Fri Oct 03 12:49:55 EDT 2025
Tue Nov 04 02:00:11 EST 2025
Fri Jul 11 10:26:07 EDT 2025
Thu Nov 13 04:31:06 EST 2025
Tue Nov 18 21:29:59 EST 2025
Tue Jul 25 20:58:58 EDT 2023
Tue Aug 26 16:33:24 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Language English
License This is an open access article under the CC BY-NC-ND license.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c549t-58b64bfbd03be29d3a212328dd7e4b411df8d9d5acbf7659d786d554c263b0df3
Notes ObjectType-Case Study-2
SourceType-Scholarly Journals-1
ObjectType-Feature-4
content type line 23
ObjectType-Report-1
ObjectType-Article-3
ORCID 0000-0003-0779-028X
0000-0003-3633-4742
OpenAccessLink https://doaj.org/article/369675e46121473996046d8c6fe1e0f9
PMID 34141847
PQID 2543443921
PQPubID 23479
ParticipantIDs doaj_primary_oai_doaj_org_article_369675e46121473996046d8c6fe1e0f9
pubmedcentral_primary_oai_pubmedcentral_nih_gov_8184500
proquest_miscellaneous_2543443921
crossref_primary_10_1016_j_gore_2021_100795
crossref_citationtrail_10_1016_j_gore_2021_100795
elsevier_sciencedirect_doi_10_1016_j_gore_2021_100795
elsevier_clinicalkey_doi_10_1016_j_gore_2021_100795
PublicationCentury 2000
PublicationDate 2021-08-01
PublicationDateYYYYMMDD 2021-08-01
PublicationDate_xml – month: 08
  year: 2021
  text: 2021-08-01
  day: 01
PublicationDecade 2020
PublicationTitle Gynecologic oncology reports
PublicationYear 2021
Publisher Elsevier Inc
Elsevier
Publisher_xml – name: Elsevier Inc
– name: Elsevier
References Walker, Powell, Chen (b0050) 2015; 121
Kotsopoulos, Gronwald, Karlan (b0020) 2018; 4
Piedimonte, Frank, Laprise, Quaiattini, Gotlieb (b0035) 2020; 135
Finch, Shaw, Rosen, Murphy, Narod, Colgan (b0015) 2006; 100
Kuchenbaecker, Hopper, Barnes (b0025) 2017; 317
Shu, Pike, Jotwani (b0045) 2016; 2
Callahan, Crum, Medeiros (b0005) 2007; 25
Cass, Walts, Karlan (b0010) 2010; 117
Marchetti, De Felice, Boccia (b0030) 2018; 132
Reade, McVey, Tone (b0040) 2014; 36
Piedimonte (10.1016/j.gore.2021.100795_b0035) 2020; 135
Shu (10.1016/j.gore.2021.100795_b0045) 2016; 2
Finch (10.1016/j.gore.2021.100795_b0015) 2006; 100
Callahan (10.1016/j.gore.2021.100795_b0005) 2007; 25
Marchetti (10.1016/j.gore.2021.100795_b0030) 2018; 132
Walker (10.1016/j.gore.2021.100795_b0050) 2015; 121
Cass (10.1016/j.gore.2021.100795_b0010) 2010; 117
Kotsopoulos (10.1016/j.gore.2021.100795_b0020) 2018; 4
Reade (10.1016/j.gore.2021.100795_b0040) 2014; 36
Kuchenbaecker (10.1016/j.gore.2021.100795_b0025) 2017; 317
References_xml – volume: 121
  start-page: 2108
  year: 2015
  end-page: 2120
  ident: b0050
  article-title: Society of Gynecologic Oncology recommendations for the prevention of ovarian cancer
  publication-title: Cancer.
– volume: 100
  start-page: 58
  year: 2006
  end-page: 64
  ident: b0015
  article-title: Clinical and pathologic findings of prophylactic salpingo-oophorectomies in 159 BRCA1 and BRCA2 carriers
  publication-title: Gynecol. Oncol.
– volume: 117
  start-page: 27
  year: 2010
  end-page: 31
  ident: b0010
  article-title: Does risk-reducing bilateral salpingo-oophorectomy leave behind residual tube?
  publication-title: Gynecol. Oncol.
– volume: 135
  start-page: 498
  year: 2020
  end-page: 508
  ident: b0035
  article-title: Occult Tubal Carcinoma After Risk-Reducing Salpingo-oophorectomy: A Systematic Review
  publication-title: Obstet Gynecol.
– volume: 2
  start-page: 1434
  year: 2016
  end-page: 1440
  ident: b0045
  article-title: Uterine Cancer After Risk-Reducing Salpingo-oophorectomy Without Hysterectomy in Women With BRCA Mutations
  publication-title: JAMA Oncol.
– volume: 25
  start-page: 3985
  year: 2007
  end-page: 3990
  ident: b0005
  article-title: Primary fallopian tube malignancies in BRCA-positive women undergoing surgery for ovarian cancer risk reduction
  publication-title: J Clin Oncol.
– volume: 317
  start-page: 2402
  year: 2017
  end-page: 2416
  ident: b0025
  article-title: Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers
  publication-title: JAMA.
– volume: 132
  start-page: 111
  year: 2018
  end-page: 115
  ident: b0030
  article-title: Hormone replacement therapy after prophylactic risk-reducing salpingo-oophorectomy and breast cancer risk in BRCA1 and BRCA2 mutation carriers: A meta-analysis
  publication-title: Crit Rev Oncol Hematol.
– volume: 36
  start-page: 133
  year: 2014
  end-page: 140
  ident: b0040
  article-title: The fallopian tube as the origin of high grade serous ovarian cancer: review of a paradigm shift
  publication-title: J Obstet Gynaecol Can.
– volume: 4
  start-page: 1059
  year: 2018
  end-page: 1065
  ident: b0020
  article-title: Hormone Replacement Therapy After Oophorectomy and Breast Cancer Risk Among BRCA1 Mutation Carriers
  publication-title: JAMA Oncol.
– volume: 100
  start-page: 58
  issue: 1
  year: 2006
  ident: 10.1016/j.gore.2021.100795_b0015
  article-title: Clinical and pathologic findings of prophylactic salpingo-oophorectomies in 159 BRCA1 and BRCA2 carriers
  publication-title: Gynecol. Oncol.
  doi: 10.1016/j.ygyno.2005.06.065
– volume: 2
  start-page: 1434
  issue: 11
  year: 2016
  ident: 10.1016/j.gore.2021.100795_b0045
  article-title: Uterine Cancer After Risk-Reducing Salpingo-oophorectomy Without Hysterectomy in Women With BRCA Mutations
  publication-title: JAMA Oncol.
  doi: 10.1001/jamaoncol.2016.1820
– volume: 4
  start-page: 1059
  issue: 8
  year: 2018
  ident: 10.1016/j.gore.2021.100795_b0020
  article-title: Hormone Replacement Therapy After Oophorectomy and Breast Cancer Risk Among BRCA1 Mutation Carriers
  publication-title: JAMA Oncol.
  doi: 10.1001/jamaoncol.2018.0211
– volume: 121
  start-page: 2108
  issue: 13
  year: 2015
  ident: 10.1016/j.gore.2021.100795_b0050
  article-title: Society of Gynecologic Oncology recommendations for the prevention of ovarian cancer
  publication-title: Cancer.
  doi: 10.1002/cncr.29321
– volume: 36
  start-page: 133
  issue: 2
  year: 2014
  ident: 10.1016/j.gore.2021.100795_b0040
  article-title: The fallopian tube as the origin of high grade serous ovarian cancer: review of a paradigm shift
  publication-title: J Obstet Gynaecol Can.
  doi: 10.1016/S1701-2163(15)30659-9
– volume: 135
  start-page: 498
  issue: 3
  year: 2020
  ident: 10.1016/j.gore.2021.100795_b0035
  article-title: Occult Tubal Carcinoma After Risk-Reducing Salpingo-oophorectomy: A Systematic Review
  publication-title: Obstet Gynecol.
  doi: 10.1097/AOG.0000000000003702
– volume: 132
  start-page: 111
  year: 2018
  ident: 10.1016/j.gore.2021.100795_b0030
  article-title: Hormone replacement therapy after prophylactic risk-reducing salpingo-oophorectomy and breast cancer risk in BRCA1 and BRCA2 mutation carriers: A meta-analysis
  publication-title: Crit Rev Oncol Hematol.
  doi: 10.1016/j.critrevonc.2018.09.018
– volume: 25
  start-page: 3985
  issue: 25
  year: 2007
  ident: 10.1016/j.gore.2021.100795_b0005
  article-title: Primary fallopian tube malignancies in BRCA-positive women undergoing surgery for ovarian cancer risk reduction
  publication-title: J Clin Oncol.
  doi: 10.1200/JCO.2007.12.2622
– volume: 317
  start-page: 2402
  issue: 23
  year: 2017
  ident: 10.1016/j.gore.2021.100795_b0025
  article-title: Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers
  publication-title: JAMA.
  doi: 10.1001/jama.2017.7112
– volume: 117
  start-page: 27
  issue: 1
  year: 2010
  ident: 10.1016/j.gore.2021.100795_b0010
  article-title: Does risk-reducing bilateral salpingo-oophorectomy leave behind residual tube?
  publication-title: Gynecol. Oncol.
  doi: 10.1016/j.ygyno.2009.12.023
SSID ssj0001503765
Score 2.1913931
Snippet •BRCA1/2 carriers are at high risk for fallopian tube carcinoma, which can arise in the proximal fallopian tube.•Pathologic analysis of RRBSO specimens should...
Patients with BRCA mutations are at high risk of high grade serous ovarian cancer. A paradigm shift has resulted in the current understanding that many cases...
• BRCA1/2 carriers are at high risk for fallopian tube carcinoma, which can arise in the proximal fallopian tube. • Pathologic analysis of RRBSO specimens...
SourceID doaj
pubmedcentral
proquest
crossref
elsevier
SourceType Open Website
Open Access Repository
Aggregation Database
Enrichment Source
Index Database
Publisher
StartPage 100795
SubjectTerms Case Reports and Case Series
Title Ovarian cancer arising from the proximal fallopian tube in a patient with a BRCA2 mutation
URI https://www.clinicalkey.com/#!/content/1-s2.0-S2352578921000990
https://dx.doi.org/10.1016/j.gore.2021.100795
https://www.proquest.com/docview/2543443921
https://pubmed.ncbi.nlm.nih.gov/PMC8184500
https://doaj.org/article/369675e46121473996046d8c6fe1e0f9
Volume 37
WOSCitedRecordID wos000701677400011&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVAON
  databaseName: DOAJ Open Access Full Text
  customDbUrl:
  eissn: 2352-5789
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0001503765
  issn: 2352-5789
  databaseCode: DOA
  dateStart: 20140101
  isFulltext: true
  titleUrlDefault: https://www.doaj.org/
  providerName: Directory of Open Access Journals
– providerCode: PRVHPJ
  databaseName: ROAD: Directory of Open Access Scholarly Resources
  customDbUrl:
  eissn: 2352-5789
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0001503765
  issn: 2352-5789
  databaseCode: M~E
  dateStart: 20150101
  isFulltext: true
  titleUrlDefault: https://road.issn.org
  providerName: ISSN International Centre
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELagQogLojzE8qhciRuKsBM7to9t1YpLH0IgrbhYdmxDUJtW290e-e3MxMkqubQXLpGS2I4zHmdmMjPfEPIpMK1EzV3BnPCFqFlTmChDoUypgxBGBJGLTaizM71cmotJqS-MCcvwwJlwX7DenJJRINKVUFUPJlIH3dQp8shSn7rHlJkYUzk_mMHOkX1lOQnWltJmyJjJwV2_ECIS7H7eRwlgcYmJVOrB-2fCaaJ8zkMnJ7Lo5AV5PiiR9CBPfpc8it1L8vR0cJO_Ij_P78AEdh1tcE1XFAsNgoiimEtCQeOjGLzSXsEQCf3uN9h0vfGRth11dIBapfiLFk4Pvx0dlPRqk332r8mPk-PvR1-LoYhC0YDpty6k9rXwyQdW-ViaUDkUVrAQQUXhBech6WCCdI1PQDETlK4D6BhNWVeehVS9ITvddRffEsqMcw7RJRkYbZxH5yXaG2VKYEdXUi8IH4lomwFhHAtdXNoxlOyPRcJbJLzNhF-Qz9s-Nxlf497Wh7g225aIjd1fAI6xA8fYhzhmQapxZe2YfgofTBiovffRcttrUE6y0vFgv_2ReSzsXHTHuC5eb24twhAI0AdLviBqxlWz95vf6drfPQY46FlCMvbufxDkPXmGE85hjR_Iznq1iR_Jk-Zu3d6u9shjtdR7_faC4-nf43-ODCVj
linkProvider Directory of Open Access Journals
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Ovarian+cancer+arising+from+the+proximal+fallopian+tube+in+a+patient+with+a+BRCA2+mutation&rft.jtitle=Gynecologic+oncology+reports&rft.au=Badiner%2C+Nora&rft.au=Nchako%2C+Corbyn+M.&rft.au=Ma%2C+Lucy&rft.au=Frey%2C+Melissa+K.&rft.date=2021-08-01&rft.pub=Elsevier+Inc&rft.issn=2352-5789&rft.eissn=2352-5789&rft.volume=37&rft_id=info:doi/10.1016%2Fj.gore.2021.100795&rft.externalDocID=S2352578921000990
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2352-5789&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2352-5789&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2352-5789&client=summon